TherapeuTic advances in vaccines and immunotherapy population across 47 countries
includes male vaccination within their routine immunization programs. 5 The HPV vaccine …

ABSTRACT After the Japanese Ministry of Health, Labor and Welfare (MHLW) suspended its
recommendation for the human papillomavirus (HPV) vaccine in June 2013, the rate of …

To the editor, In Japan, vaccination with public aid against the human papillomavirus (HPV)
became available to girls aged 13–16 in 2010. However, early in the spring of 2013, the …

Cervical cancer is prevalent among women, with a reported 604,127 cases in 2020
worldwide. The incidence of cervical cancer has been mitigated in most high-income …

In June 2013, the Japanese Ministry of Health, Labour, and Welfare (MHLW) suspended its
active recommendation of the human papillomavirus (HPV) vaccination after a small number …

It has been over 10 y since the first HPV vaccines were licensed and introduced in a number
of countries around the world. As only the second vaccine (after hepatitis B) that prevents an …

Japan has a particularly critical situation surrounding its collapsed HPV vaccination program
for preventing HPV‐caused cervical cancers, a problem exacerbated by the lack of a …

Human papillomaviruses (HPV) can cause numerous cancers in males and females,
including anogenital cancers. Cervical cancer, which is mainly caused by HPV, is one of the …

In Japan, cervical cancer has the highest incidence rate among cancers affecting women
aged 15–39, with human papillomavirus (HPV) infection reported as the primary cause. 1 …

Background Proactive recommendations for human papillomavirus (HPV) vaccines in Japan
have been suspended for 5 years because of safety concerns. While no scientific evidence …